grant_single_labels|summary

grant_single|eligibleFinancing
  • grant_single|noCondition
grant_single|deadlines
  • grant_single|openingDateNovember 14, 2019
grant_single|financingType
Researchers And Facilities
Expert Advice
grant_single|eligibleIndustries
  • Manufacturing
  • Professional, scientific and technical services
  • Health care and social assistance
grant_single|grantors
  • National Research Council Canada (NRC)
  • Government of Canada
grant_single|status
grant_card_status|open

grant_single_labels|preview

Access technical and advisory services, research facilities and licensing opportunities for human health therapeutics research.

grant_single_labels|projects

grant_single|admissibleProjectsExample

$ 750,000

Creation of an innovative biologic to tackle autoimmune diseases

$ 900,000

Research and development of novel biologics for cancer treatment

$ 600,000

Development of a new gene therapy targeting rare genetic disorders

$ 750,000

Production of a novel biologic for infectious disease treatment

$ 850,000

Development of cell therapy for treating cardiovascular diseases

$ 400,000

Optimization of biomanufacturing processes for complex biologics

grant_single_labels|admissibility

grant_eligibility_criteria|eligible_expenses

This grant supports initiatives aimed at advancing biologics development and production, with a focus on tackling complex health challenges. Eligible projects include collaboration across research and development, innovative production processes, and therapy advancements.
  • Design and development of innovative biologics for emerging infections, cancer, and neurological diseases.
  • Biomanufacturing improvements to optimize production processes for complex biologics.
  • Advancement of cell and gene therapies through collaborative projects.
  • Preclinical research and development utilizing in vivo and in vitro testing.
  • Scaling up bioprocesses for clinical trial material production compliant with GMP.
  • Collaborative research initiatives to combat antimicrobial resistance.
  • Development of CAR T-cell cancer therapies made in Canada.

grant_single_labels|criteria

There are evaluation and selection criteria for this grant. The evaluation and selection criteria are as follows:
  • Relevance of the project to advancing novel biologics
  • Scientific merit and innovation of the proposed research
  • Feasibility and technical soundness of the project
  • Alignment with the organization's strategic priorities
  • Potential impact on public health and patient outcomes

grant_single_labels|apply

1

2

3

4

5

grant_single_labels|otherInfo

Here are additional relevant details for this grant:
  • Collaboration with industry, hospitals, health networks, academia, and government is encouraged to advance novel biologics.
  • Access to multidisciplinary expertise and leading-edge facilities is available for the biologics development process, from discovery to clinical material production.
  • Support for generating high-potential candidates using advanced proprietary technologies is provided.
  • Preclinical R&D capabilities include small-scale manufacturing and both in vivo and in vitro testing expertise.
  • Bioprocess improvements can be conducted in specialized R&D labs focusing on analytics, modelling, and intensification.
  • Production facilities are available for optimizing bioprocesses and producing clinical trial materials compliant with good manufacturing practices (GMP).
  • A directory of science professionals and researcher profiles is accessible, offering insights into their projects and expertise.

grant_single_labels|documents

NRC — Human Health Therapeutics Research Centre

Apply to this program

More grants like this

Innovation for Defence Excellence and Security (IDEaS) -
Grant and Fundinggrant_card_status|open
Funding projects for innovative defence and security solutions
Developmental Licence Playbook -
Other Supportgrant_card_status|open
Access wireless spectrum to test a business idea
Patent -
Other Supportgrant_card_status|open
Apply for a patent
CENGN — Centre of Excellence in Next Generation Networks -
Researchers And FacilitiesPartnering and Collaborationgrant_card_status|open
Accelerate your path to commercialization
Proof-of-Concept Program -
Grant and Fundinggrant_card_status|open
Financing for natural product innovations
MaRS Momentum -
Expert Advicegrant_card_status|open
Support for high-growth science and technology companies
Accelerated Growth Program -
Expert Advicegrant_card_status|open
Support for technology startups
Fast-Track to Financing Program -
Grant and Fundinggrant_card_status|open
Funding to engage an expert
CRIM —Support -
Expert Advicegrant_card_status|open
Support for technological innovation projects
TECHNATION — Career Ready Program -
Wage Subsidies And Internsgrant_card_status|open
Wage subsidy for developing tech talent